ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy

ClinicalTrials.gov ID: NCT01513759

Public ClinicalTrials.gov record NCT01513759. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 2:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Single-Arm, Multi-Center Trial of EkoSonic® Endovascular System and Activase for Treatment of Acute Pulmonary Embolism (PE)

Study identification

NCT ID
NCT01513759
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boston Scientific Corporation
Industry
Enrollment
150 participants

Conditions and interventions

Interventions

  • EKOS EkoSonic Endovascular System Device
  • recombinant tissue plasminogen activator Drug

Device · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 6, 2012
Primary completion
Feb 16, 2013
Completion
Feb 16, 2013
Last update posted
Jul 18, 2021

2012 – 2013

United States locations

U.S. sites
22
U.S. states
16
U.S. cities
21
Facility City State ZIP Site status
Baptist Health Montgomery Alabama 36116
Memorial Medical Center Modesto California 95355
Stanford University Medical Center Stanford California 94305
Hartford Hospital Hartford Connecticut
Christiana Hospital Newark Delaware 19718
Lakeland Regional Medical Center Lakeland Florida 33805
Holmes Regional Medical Center Melbourne Florida 32901
Florida Hospital Orlando Florida 32803
Orlando Regional Medical Center Orlando Florida 32806
Medical Center of Central Georgia Macon Georgia 31201
Prairie Heart Institute Springfield Illinois 62701
St. Vincent Hospital Indianapolis Indiana
University of Kentucky, Gill Heart Institute Lexington Kentucky 40536
East Jefferson General Hospital New Orleans Louisiana 70006
Hackensack University Medical Center Hackensack New Jersey 07601
Overlook Medical Center Morristown New Jersey 07960
Holy Name Hospital Teaneck New Jersey 07666
Montefiore Medical Center The Bronx New York 10467
Mt. Carmel East Columbus Ohio 43213
The Miriam Hospital Providence Rhode Island 02906
Providence Memorial and Sierra Medical Center El Paso Texas 79902
Inova Alexandria Hospital Alexandria Virginia 22304

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01513759, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 18, 2021 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01513759 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →